Privacy Statement - Processing of personal data for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
Training course on control of multidrug-resistant micro-organisms in health care settings
ECDC is organising a short course on “Control of multidrug-resistant micro-organisms (MDROs) in health care settings”. This training opportunity is addressed at healthcare professionals from European Union (EU) and European Economic Area (EEA) countries with current or future responsibility for the prevention and control of healthcare-associated infections (HAIs) due to MDROs working at national or local level. The course is offered by invitation only and participants are identified through the ECDC Coordinating Competent Bodies.
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.
Developing a reporting system for the surveillance of HIV drug resistance in Europe
A pilot project was carried out to investigate the feasibility of HIVDR surveillance in EU/EEA countries and to make recommendations for the design and implementation of a potential future HIVDR surveillance system at the European level.
Annual meeting of the Technical Advisory Committee for the European Antibiotic Awareness day (EAAD)
The EAAD Technical Advisory Committee (TAC) meets once a year to provide technical advice and the strategic direction for EAAD. In 2019 the meeting will be held in Stockholm on 22 - 24 May.
World Hand Hygiene Day 2019
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization (WHO) to improve hand hygiene in healthcare settings.
Extensively drug-resistant gonorrhoea: risk of further dissemination within and across Europe
ECDC comment on the study 'Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018' by Eyre et al. in the Eurosurveillance edition of 7 March 2019.
Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico
This outbreak of Verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) surgical site infections, related to invasive procedures performed in healthcare facilities in Tijuana, Baja California, Mexico, highlights the risks associated with medical tourism for patients and healthcare systems in the countries of origin.
Gonorrhoea: drug resistance compromises recommended treatment in Europe
Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme.
Zoonoses: antimicrobial resistance shows no signs of slowing down
Data released today by the European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) reveal that antimicrobials used to treat diseases that can be transmitted between animals and humans, such as campylobacteriosis and salmonellosis, are becoming less effective.